Prosecution Insights
Last updated: November 12, 2026
Application No. 18/643,780

OVERALL ENDOSCOPIC CONTROL SYSTEM

Final Rejection §DP
Filed
Apr 23, 2024
Priority
Mar 07, 2012 — provisional 61/607,661 +4 more
Examiner
CHOU, WILLIAM B
Art Unit
3795
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Asensus Surgical Europe S.à r.l.
OA Round
2 (Final)
73%
Grant Probability
Favorable
3-4
OA Rounds
93%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
397 granted / 546 resolved
+2.7% vs TC avg
Strong +21% interview lift
Without
With
+20.6%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
17 currently pending
Career history
571
Total Applications
across all art units

Office Action

§DP
DETAILED ACTION The present application is being examined under the pre-AIA first to invent provisions. DOUBLE PATENTING The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-11 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-8 of U.S. Patent No. 11,963,666. Although the claims at issue are not identical, they are not patentably distinct from each other because the overlapping subject matter of U.S. Patent No. 11,963,666 regarding a method for controlling an endoscope reads on the subject matter of the instant application regarding a method for controlling an endoscope. Instant Application U.S. Patent 11,963,666 1. A method for controlling an endoscope comprising steps of: displaying in real time images of a field of view (FOV) acquired by an endoscope within a body cavity, said FOV defining at least two axes of an endoscope coordinate system that is fixed with respect to the displayed images and configured to be real time updated as at least a tip of said endoscope moves and said FOV changes; receiving as user input FOV commands of motions to maneuver said at least a tip of said endoscope in real time in a desired direction, said FOV commands of motion being commands of motion relative to at least two axes selected from said FOVx-axis, said FOVy-axis and said FOVz-axis, as real time displayed in said image; converting said FOV commands of motion to maneuvering system commands of motions for a maneuvering system configured to maneuver at least a tip of said endoscope in at least two DOF; said maneuvering system defining a constant x-axis, a constant y-axis and a constant z-axis, said maneuvering system commands of motion being commands of motion relative to said x-axis, said y-axis and said z-axis; and causing said maneuvering system to maneuver said at least a tip of said endoscope according to said maneuvering system commands of motions. 1. A method for controlling an endoscope comprising steps of: displaying in real time images of a field of view (FOV) acquired by an endoscope within a body cavity, said FOV defining at least two axes of a coordinate system fixed with respect to the camera and the displayed images, said at least two axes selected from a group consisting of FOVx-axis, FOVy-axis and FOVz-axis and any combination thereof, such that at least two axes selected from said FOVx-axis, said FOVy-axis, said FOVz-axis and any combination thereof are configured to be real time updated as at least a tip of said endoscope moves and said FOV changes; receiving as user input FOV commands of motions to maneuver said at least a tip of said endoscope in real time in a desired direction, said FOV commands of motion being commands of motion relative to at least two axes selected from said FOVx-axis, said FOVy-axis and said FOVz-axis, as real time displayed in said image; converting said FOV commands of motion to maneuvering system commands of motions for a maneuvering system configured to maneuver at least a tip of said endoscope in at least two DOF; said maneuvering system defining a constant x-axis, a constant y-axis and a constant z-axis, said maneuvering system commands of motion being commands of motion relative to said x-axis, said y-axis and said z-axis; and causing said maneuvering system to maneuver said at least a tip of said endoscope according to said maneuvering system commands of motions. Response to Arguments Examiner acknowledges the receipt of the Applicant’s Amendment dated July 9, 2026. Applicant amended claims 1 and 6. Applicant added new claims 8-11. Claim Objections Applicant amended claims 1 and the previous objection is withdrawn. Allowable Subject Matter Claims 1-11 allowed. The following is an examiner’s statement of reasons for allowance: Popovic discloses various aspects of the invention as to a method for controlling an endoscope, positioning an endoscope, displaying real time images, receiving from a touch screen FOV commands of motion, and converting said FOV commands of motion to maneuvering system commands of motions. However the prior art does not disclose or fairly suggest the method for controlling an endoscope such that maneuvering system commands of motions generated from FOV commands of motions are defined by a FOV with a coordinate system fixed with respect to the displayed images as cited in claim 1. Claims 2-11 are dependent from claim 1 and similarly allowable. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to WILLIAM B CHOU whose telephone number is (571) 270-3367. The examiner can normally be reached on M-F 9 am - 6 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Carey can be reached on (571) 270-7235. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WILLIAM CHOU/ Examiner, Art Unit 3795 /MICHAEL J CAREY/Supervisory Patent Examiner, Art Unit 3795
Read full office action

Prosecution Timeline

Apr 23, 2024
Application Filed
Jan 09, 2026
Non-Final Rejection mailed — §DP
Jul 09, 2026
Response Filed
Sep 25, 2026
Final Rejection mailed — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788226
Method And System For Providing Visual Guidance To An Operator For Steering A Tip Of An Endoscopic Device Towards One Or More Landmarks In A Patient
5y 11m to grant Granted Nov 10, 2026
Patent 12788211
ASSISTANT DEVICE, ENDOSCOPIC SYSTEM, ASSISTANT METHOD, AND COMPUTER-READABLE RECORDING MEDIUM
3y 7m to grant Granted Nov 10, 2026
Patent 12788233
Controlled Motion Capsule
2y 11m to grant Granted Nov 10, 2026
Patent 12773091
HAND-HELD, ROBOTIC-ASSISTED ENDOSCOPE
4y 1m to grant Granted Oct 27, 2026
Patent 12741378
DETERMING AN ERGONOMIC CENTER FOR AN INPUT CONTROL
4y 8m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
73%
Grant Probability
93%
With Interview (+20.6%)
Moderate
PTA Risk
Based on 546 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month